DEO PEPPERSACK: Open Payments
NPI 1770538811 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 114 payments from 8 companies in 2025. Trend: 2023 $1,103 · 2024 $1,077 · 2025 $1,335
Food & beverage: $1,159Education: $176
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $317 |
| Neurocrine BioSciences, Inc. | 26 | $267 |
| Teva Pharmaceuticals USA, Inc. | 13 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $221 |
| ABBVIE INC. | 33 | $204 |
| Corium, LLC | 8 | $50 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: INGREZZA, CAPLYTA, REXULTI, VRAYLAR, ABILIFY MAINTENA, ABILIFY ASIMTUFII, Azstarys, UBRELVY.
Industry payments across ID — which companies pay providers there.
